• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Technology Events 2025-2026
  • Sponsored Post
    • Make a Contribution
  • Technology Jobs
  • Technology Markets
  • About
    • GDPR
  • Contact

GenEdit Closes $8.5 million Series Seed Financing

December 11, 2018 By admin Leave a Comment

GenEdit, Inc., a developer of novel polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics, today announced the completion of a $8.5 million Series Seed financing round led by new investors Data Collective Bio (DCVC Bio) and SK Holdings. Also participating in the round are pre-seed investors, including Sequoia Capital and Bow Capital. DCVC Bio Managing Partner, Kiersten Stead, Ph.D., and Natera co-founder and CEO, Matthew Rabinowitz, Ph.D., joined GenEdit’s Board of Directors.

This round will help the company continue to build and advance its proprietary polymer nanoparticle system. GenEdit’s technology will address one of the biggest challenges in gene therapy and gene editing which is safe and efficient delivery to the target tissues.

GenEdit has roots at the University of California, Berkeley and officially launched in 2016. The founders include UC Berkeley scientists, Kunwoo Lee, Hyo Min Park, and Niren Murthy, who is Professor of Bioengineering. Since then, the team has developed its proprietary polymer nanoparticle library, establishing initial proof of concept by delivering CRISPR-Cas9 and gene editors to target tissues, leading to publications in key journals including Nature Biomedical Engineering (Duchenne Muscular Dystrophy, 2017) and Nature Biomedical Engineering (Autism, 2018), Nature Comm (CRISPR/Cas12a, 2018).

“We’re excited to lead this financing and help this team take the company to the next level,” said Dr. Stead, DCVC Bio Managing partner. “We recognized the tremendous opportunity that GenEdit’s technology will have in the gene editing field and look forward to supporting the company translate the promise of its platform.”

“We believe GenEdit could be a leading gene editing company with the unique platform technology which can overcome side effects of traditional delivery methods,” said Jinsoo Lee, Project Leader of Global Business Development team in SK Holdings. “SK looks forward to supporting this team to develop their potential for curing many genetic diseases.”

“With its cutting-edge delivery technologies, GenEdit is uniquely positioned to lead the next generation of gene therapy companies,” said Dr. Rabinowitz, CEO of Natera. “I’m delighted to be joining the GenEdit board and to be working with a great company and a technology platform with which we can target diseases with serious unmet needs.”

“We founded GenEdit to solve delivery problem, which is a big challenge in gene therapy. This financing validates our systematic approach with novel polymer library and the potential to bring life-changing gene therapies to patients suffering from serious diseases,” said Kunwoo Lee, co-founder and CEO of GenEdit. “The funding will enable us to demonstrate proof of concept and position us to develop a pipeline of non-viral novel gene-editing-based therapeutics.”

About Data Collective Bio (DCVC Bio)

Data Collective (DCVC) backs entrepreneurs applying deep tech to transform giant industries. DCVC and its principals have supported brilliant people changing global-scale businesses for over twenty years, helping create tens of billions of dollars of value while also making the world a markedly better place.

About SK Holdings

SK Holdings continues to enhance its portfolio value by executing long-term investments with a number of competitive subsidiaries in various business areas, including pharmaceuticals and life science, energy and chemicals, information and telecommunication, and semiconductors. In addition, SK Holdings is focused on reinforcing its growth foundations through profitable and practical management based on financial stability, while raising its enterprise value by investing in new future growth businesses. For more information, please visit http://hc.sk.co.kr/en/.

About GenEdit

GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s technology platform solves current delivery challenges by systematically screening its proprietary nanoparticle library and providing safer and efficient delivery to target tissues. GenEdit’s proprietary nanoparticles has broad applicability including the development of CRISPR-based therapeutics and gene therapy products for a wide range of genetic diseases.

For more information, please visit www.genedit.com.

Filed Under: Tech

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • Adobe Introduces LLM Optimizer to Help Brands Navigate the Generative AI Shift
  • Why Visa and Mastercard Stocks Slipped After the Stablecoin News
  • iOS 26: The Most Personal, Intelligent, and Private iPhone Experience Yet
  • Postman Unveils Agentic AI Tooling to Operationalize API-Driven Intelligence
  • AM Batteries Opens New Facility in Billerica to Advance U.S. Battery Supply Chain
  • Meibel Secures $7 Million to Revolutionize AI Runtime Management
  • Tailor Raises $14 Million to Redefine ERP for Modern Businesses with Composable Architecture
  • Intel Unveils New GPUs and AI Accelerators at Computex 2025
  • Unlocking Critical Minerals: USGS Invites States to Turn Mine Waste into Treasure
  • Blacksmith Reimagines Continuous Integration with AI-Optimized Infrastructure

Media Partners

  • Market Analysis
  • Cybersecurity Market
China’s Strategic Shift to RISC-V: Market Implications and Growth Prospects
Understanding Transfer Pricing: A Key Component of Multinational Business Operations
A Comprehensive Tour of Project Management Tools and Integration Platforms
Implementing Odoo ERP in a Small Manufacturing Enterprise: Costs and Considerations
Economic Optimism Meets Uncertainty: Blue Chip Indicators Highlight Post-Election Fiscal Concerns and AI’s Looming Impact
The Future of Connectivity: Insights from Ericsson’s November 2024 Mobility Report
Platinum Market Faces Sustained Deficit Amidst Strong Demand and Constrained Supply
Breaking Beijing’s Grip: U.S. and Australia Unite Against China’s Rare Earth Monopoly
Global AI-Powered Accounting and Audit Services Market Analysis 2023-2030: Growth, Trends, and Forecast
The Re-Emergence of PHP
Passwork Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Enterprise Security
Halo Security Honored with 2025 MSP Today Product of the Year Award
Cloudflare Log Explorer: A Unified Security and Performance Lens Within the Dashboard
The Rising Tide: AI and Cybersecurity Challenges Loom Large for CISOs
Arsen Launches AI-Powered Vishing Simulation to Help Organizations Combat Voice Phishing at Scale
Cyera Raises $540M to Cement Its Role as AI’s Data Security Backbone
ZeroRISC Secures $10M to Build Transparent, Secure Supply Chains
Cisco Fuses AI Security Into the Network Fabric: A Unified Vision for the Agentic Era
Guardz Raises $56M Series B to Scale AI-Native Cybersecurity Platform for MSPs and SMBs
Horizon3.ai’s $100M Bet on Autonomous Security

Media Partners

  • Market Research Media
  • Technology Conferences
The Rise of Headless Content Frameworks in Distributed Media Projects
Developing Web Projects: From Concept to Launch
The Rise of APS-C Cameras: A Professional Renaissance in Photography
Market Brief: Disruption in Spanish Orange Supply Chain and Strategic Response by UK Retailers
Global AI-Powered Movie Scenario Market Analysis 2023-2030: Growth, Trends, and Forecast
Market Research Report: US Government Cybersecurity Market in 2024
Market Research Report: Global Advertising Revenue Projections and Trends in the Entertainment & Media Industry
Social Media: The Rise of Formulaic Content
Netflix’s Creative Decline: The Rise of Formulaic Content
The Transformation of Media: Navigating the Waning Allure of Social Platforms
Apple Announces WWDC25, June 9 to 13, 2025
Adobe Summit 2025, March 17-20, Las Vegas
Embedded World 2025, from 11 to 13 March 2025 in Nuremberg
SATELLITE 2025: Uniting the Global Satellite and Space Communities
The milestone 10th edition of Chatbot Summit on March 31 – April 1, 2025, The Ritz-Carlton, Berlin
Snowflake Summit 2025, scheduled for June 2-5, 2025, in San Francisco
The NVIDIA GPU Technology Conference (GTC) 2025 is set to take place from March 17 to 21 at the San Jose McEnery Convention Center in San Jose, California
The Taipei Nangang Exhibition Center is set to host COMPUTEX 2025 from May 20 to May 23
The Mobile World Congress (MWC 2025) will kick off from March 3 to 6 in Barcelona, Spain
IOT Solutions World Congress 2025: Forging the Future of Industrial Innovation

Copyright © 2022 Technologies.org

Media Partners: Market Analysis & Market Research and Exclusive Domains